Clinical Trial Update: Dual-targeting HER2 and PD-L1 CAR-T for Solid Tumors [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) trial is evaluating a dual-targeting CAR-T therapy against HER2 and PD-L1 for solid tumors, including metastatic peritoneal carcinoma a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignancies
• Malignant Pleural Effusion
• Peritoneal Carcinoma

Drugs mentioned

• Dual-targeting HER2 and PD-L1 CAR-T

Snippet

Sponsor: Sichuan University | Conditions: Peritoneal Carcinoma Metastatic, Pleural Effusion, Malignant | EARLY_Phase 1 | Status: RECRUITING